Phytoestrogens and bone health

Phytochemical Functional Foods

Volumn , Issue , 2003, Pages 88-106

  Offord, E ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953572670     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-85573-672-6.50010-1     Document Type: Chapter

References (115)

1. D L ALEKEL, A ST GERMAIN, C T PETERSON, K B HANSON, J W STEWART and T TODA (2000) ‘Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.’. Am J Clin Nutr 72 844-852.
2. J J B ANDERSON and S C GARNER (1997) ‘The effects of phytoestrogens and bone.’. Nutrition Res 17 1617-1632.
3. J J B ANDERSON, W W AMBROSE and S C GARNER (1998) ‘Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model.’. Proc Soc Exp Biol Med 217 345-350.
4. W ANDLAUER, J KOLB and P FÜRST (2000) ‘Absorption and metabolism of genistin in the isolated rat small intestine.’. FEBS Lett 475 127-130.
5. J J ANDERSON, X CHEN, A BOASS, M SYMONS, M KOHLMEIER, J B RENNER and S C GARNER (2002) ‘Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year.’. J Am Coll Nutr 21 388-393.
6. B H ARJMANDI and B J SMITH (2002) ‘Soy isoflavones osteoprotective role in postmenopausal women: mechanism of action.’. J Nutr Biochem 13 130-137.
7. B H ARJMANDI, D L ALEKEL, B W HOLLIS, D AMIN, M STACEWICZ-SAPUNTZAKIS, P GUO and S C KUKREJA (1996) ‘Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis.’. J Nutr 126 161-167.
8. B H ARJMANDI, R S BIRNBAUM, N V GOYAL, M J GETLINGE, S JUMA, D L ALEKEL, C M HASLER, M L DRUM, B W HOLLIS and S C KUKREJA (1998) ‘Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content.’. Am J Clin Nutr 68 68S-1364S.
9. B H ARJMANDI, M J GETLINGER, N V GOYAL, D L ALEKEL, C M HASLER, S JUMA, M L DRUM, B W HOLLIS and S C KUKREJA (1998) ‘Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats.’. Am J Clin Nutr 68 63S-1358S.
10. B H ARJMANDI, D A KHALIL and B W HOLLIS (2000) ‘Ipriflavone, a synthetic phytoestrogen, enhances intestinal calcium transport in vitro.’. Calcif Tissue Int 67 225-229.
11. B H ARJMANDI, D A KHALIL and B W HOLLIS (2002) ‘Soy protein: its effects on intestinal calcium transport, serum vitamin D and insulin-like growth factor-I in ovariectomized rats.’. Calcif Tissue Int 70(6), 483-487.
12. B H ARJMANDI, M A SALIH, D C HERBERT, S H SIMS and D N KALU (1993) ‘Evidence for estrogen receptor-linked calcium transport in the intestine.’. Bone and Mineral 21 63-74.
13. D D BAIRD, D M UMBACH, L LANDSDELL, C L HUGHES, K D R SETCHELL, C R WEINBERG, A F HANEY, A J WILCOX and J A MCLACHLAN (1995) ‘Dietary intervention study to assess estrogenicity of dietary soy amongst postmenopausal women.’. J Clin Endocinol Metab 80(50), 1685-1690.
14. M BOLSCHER, J C NETELENBOS, R BARTO, L M VAN BUUREN and W J F VAN DER VIJCH (1999) ‘Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat.’. J Bone Min Res 14 1197-1202.
15. S BOOTH (2001) ‘Vitamin K and the skeleton,’. P Burckhardt, B Dawson-Hughes, R P Heaney,(Eds) Nutritional aspects of osteoporosis San Diego: Academic Press 273-281.
16. A CASSIDY, S BINGHAM and K D R SETCHELL (1994) ‘Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women.’. Am J Clin Nutr 60 333-340.
17. J A CAULEY, D G SEELEY, K ENSRUD, B ETTINGER, D BLACK and S R CUMMINGS (1995) ‘Estrogen replacement therapy and fractures in older women.’. Ann Intern Med 122 9-16.
18. E M CHOI, K S SUH, Y S KIM, R W CHOUE and S J KOO (2001) ‘Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells.’. Phytochemistry 56 733-739.
19. E M COLIN, G J C M VAN DEN BEMD, M VAN AKEN, S CHRISTAKOS, H R DE JONGE, H F DELUCA, J M PRAHL, J C BIRKENHÄGER, C J BUURMAN, H A P POLS and J P T M VAN LEEUWEN (1999) ‘Evidence for involvement of 17β-estradiol in intestinal calcium absorption independent of 1,25-dihydroxyvitamin D3 level in the rat.’. J Bone Min Res 14 57-64.
20. F S DALAIS, G E RICE, M L WAHLQUIST, M GREHAN, A L MURKIES, G MEDLEY, R AYTON and B J G STRAUSS (1998) ‘Effects of dietary phytoestrogens in postmenopausal women.’. Climacteric 1 124-129.
21. A J DAY, M S DUPONT, S RIDLEY, S RHODES, M J C RHODES, M R A MORGAN and G WILLIAMSON (1998) ‘Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity.’. FEBS Lett 436 71-75.
22. A DAY, F J CANADA, J C DIAZ, P A KROON, R MCLAUCHLAN, C B FAULDS, G W PLUMB, M R A MORGAN and G WILLIAMSON (2000) ‘Dietary flavonoid and isoflavone glycosides are hydrolyzed by the lactase site of lactase phlorizin hydrolase.’. FEBS Lett 468 166-170.
23. K DECHERING, C BOERSMA and S MOSSELMAN (2000) ‘Estrogen receptors α and β: two receptors of a kind?’. Curr Med Chem 7 561-576.
24. P DIEL (2002) ‘Tissue-specific estrogenic response and molecular mechanisms.’. Tox Lett 127 217-224.
25. C R DRAPER, I M DICK and R L PRINCE (1999) ‘The effect of estrogen deficiency on calcium balance in mature rats.’. Calcif Tissue Int 64 325-328.
26. P DUCY, T SCHINKE and G KARSENTY (2000) ‘The osteoblast: a sophisticated fibroblast under central surveillance.’. Science 289 1501-1504.
27. M DUNCAN, E MERZ-DEMLOW, X XU, W R PHIPPS and M S KURZER (2000) ‘Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer.’. Cancer Epidemiol Biomarkers Prev 9 581-586.
28. R EASTELL and H LAMBERT (2002) ‘Diet and healthy bones.’. Calcif Tissue Int 5 400-404.
29. P FANTI, M C MONIER-FAUGERE, Z GENG, J SCHMIDT, P E MORRIS, D COHEN and H H MALLUCHE (1998) ‘The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.’. Osteoporosis Int 8 274-281.
30. Y H GAO and M YAMAGUCHI (1999) ‘Inhibitory effect of genistein on osteoclast-like cell formation in mouse marrow cultures.’. Biochem Pharmacol 58 767-772.
31. Y H GAO and M YAMAGUCHI (1999) ‘Suppressive effect of genistein on rat bone osteoclasts: Apoptosis is induced through Ca2+ signalling.’. Biol Pharm Bull 22 805-809.
32. Y H GAO and M YAMAGUCHI (1999) ‘Anabolic effect of daidzein on cortical bone in tissue culture: Comparison with genistein effect.’. Mol Cell Biochem 194 93-98.
33. Y H GAO and M YAMAGUCHI (2000) ‘Suppressive effect of genistein on rat bone osteoclasts: Involvement of protein kinase inhibition and protein tyrosine phosphatase activation.’. Int J Mol Med 5 261-267.
34. J M GEE, M S DUPONT, M J C RHODES and I T JOHNSON (1998) ‘Quercetin glycosides interact with the intestinal glucose transport pathway.’. Free Rad Biol Med 25 19-25.
35. L A GRIFFITHS and A BARROW (1972) ‘Metabolism of flavonoid compounds in germ-free rats.’. Biochem J 72 1161-1162.
36. E HARRISON, A ADJEI, C AMEHO, S YAMAMOTO and S KONO (1998) ‘The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis.’. J Nutr Sci Vitaminol 44 257-268.
37. R HEANEY (2000) ‘Calcium, dairy products and osteoporosis.’. J Am Coll Nutr 19(2), 83-99.
38. R HEANEY (2001) ‘Calcium needs of the elderly to reduce fracture risk.’. J Am Coll Nutr 20(2), 192-197.
39. S C HO, S G CHAN, Q YI, E WONG and P C LEUNG (2001) ‘Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women.’. J Bone Min Res 16(7), 1363-1369.
40. P C H HOLLMAN, J H M DE VRIES, S D VAN LEEUWEN, M J B MENGELERS and M B KATAN (1995) ‘Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers.’. Am J Clin Nutr 62 1276-1282.
41. M L HOLZHERR, R W RETALLACK, D H GUTTERIDGE, R I PRICE, D L FAULKNER, S G WILSON, R K WILL, G O STEWART, B G STUCKEY, R L PRINCE, R A CRIDDLE, G N KENT, C I BHAGAT, S S DHALIWAL and K JAMROZIK (2000) ‘Calcium absorption in postmenopausal osteoporosis: Benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers.’. Osteoporosis Int 11 43-51.
42. T HORIUCHI, T ONOUCHI, M TAKAHASHI, H ITO and H ORIMO (2000) ‘Effect of soy protein on bone metabolism in postmenopausal Japanese women.’. Osteoporosis Int 11 721-724.
43. C S HSU, W W SHEN, Y M HSUEH and S L YEH (2001) ‘Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzye activities and bone density.’. J Reprod Med 46 221-226.
44. A M HUTCHINS, J L SLAVIN and J W LAMPE (1995) ‘Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products.’. J Am Diet Assoc 95 545-551.
45. K IOKU, Y PONGPIRIYADACHA, Y KONISHI, Y TAKEI, N NAKATANI and J TERAO (1998) ‘β-glucosidase activity in the rat small intestine toward quercetin monoglucosides.’. Bioscience Biotechnol Biochem 62 1428-1431.
46. H ISHIDA, T UESUGI, K HIRAI, T TODA, H NUKAYA, K YOKOTSUKA and K TSUJI (1998) ‘Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet.’. Biol Pharm Bulletin 21 62-66.
47. Y ISHIMI, C MIYAURA, M OHMURA, Y ONOE, T SATO, Y UCHIYAMA, M ITO, X WANG, T SUDA and S IKEGAMI (1999) ‘Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency.’. Endocrinol 140 1893-1900.
48. T IZUMI, M K PISKULA, S OSAWA, A OBATA, K TOBE, K SAITO, S KATAOKA, Y KUBOTA and M KIKUCHI (2000) ‘Soy isoflavone aglycones are asborbed faster and in higher amounts than their glucosides in humans.’. J Nutr 130 1695-1699.
49. A ISHIMI, M YOSHIDA, S MAKIMOTO, J WU, H CHIBA, X WANG, K TAKEDA and C MIYAURA (2002) ‘Genistein, a soybean isoflavone, affects bone marrow lymphopoiesis and prevents bone loss in castrated male.’. Bone 31 180-185.
50. H KAJIYA, K OKABE, F OKAMOTO, T TSUZUKI and H SOEDA (2000) ‘Protein tyrosine kinase inhibitors increase cytosolic calcium and inhibit actin organization as resorbing activity in rat osteoclasts.’. J Cell Phys 183 83-90.
51. D A KHALIL, E A LUCAS, S JUMA, B J SMITH, M E PAYTON and B H ARJMANDI (2002) ‘Soy protein supplementation increases serum insulin-like growth factor-1 in young and old men but does not affect markers of bone metabolism.’. J Nutr 132 2605-2608.
52. Z I JASMINKA (2000) ‘Nutrition in bone health revisited: a story beyond calcium.’. J Am Coll Nutr 19(6), 715-737.
53. G E KELLY, C NELSON, M A WARING, G E JOANNOU and A Y REEDER (1993) ‘Metabolites of dietary (soya) isoflavones in human urine.’. Clin Chim Acta 223 9-22.
54. G E KELLY, G E JOANNOU, A Y REEDER, C NELSON and M A WARING (1995) ‘The variable metabolic response to dietary isoflavones in humans.’. Proc Soc Exp Biol Med 208 40-43.
55. M KOMULAINEN, H KROGER, M T TUPPURAINEN, A M HEIKKINEN, E ALHAVA, R HONKANEN, J JURVELIN and S SAARIKOSKI (1999) ‘Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a populationbased 5-year randomized trial.’. J Clin Endocrinol Metab 84 546-552.
56. M C KRUGER and D F HORROBIN (1997) ‘Calcium metabolism, osteoporosis and essential fatty acids: a review.’. Prog Lipid Res 36 131-151.
57. G G J M KUIPER, B CARLSSON, K GRANDIEN, E ENMARK, J HÄGGBLAD, S NILSSON and J A GUSTAFSSON (1997) ‘Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β.’. Endocrinol 138 863-870.
58. M S KURZER and X U X (1997) ‘Dietary phytoestrogens.’. Ann Rev Nutr 17 353-381.
59. Y-S LEE, X CHEN and J B ANDERSON (2001) ‘Physiological concentrations of genistein stimulate the proliferation and protect against free radical-induced oxidative damage of MC3T3-E1 osteobast-like cells.’. Nutr Res 21 1287-1298.
60. Y LIEL, S SHANY, P SMIRNOFF and B SCHWARTZ (1999) ‘Estrogen increases 1, 25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa.’. Endocrinol 140 280-285.
61. L MARKIEWICZ, J GAREY, H ADLERCREUTZ and E GURPIDE (1993) ‘In vitro bioassays of nonsteroidal phytoestrogens.’. J Steroid Biochem Molec Biol 45 399-405.
62. D P MCDONNELL (1999) ‘The molecular pharmacology of SERMs.’. Trends Endocrinol Metab 10 301-311.
63. J MEI, S S YEUNG and A W KUNG (2001) ‘High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women,’. J Clin Endocrinol Metabol 86(11), 5217-5221.
64. M J MESSINA and C L LOPRINZI (2001) ‘Soy for breast cancer survivors: a critical review of the literature.’. J Nutr 131 3095-3108.
65. M J MESSINA, V PERSKY, K D R SETCHELL and S BARNES (1994) ‘Soy intake and cancer risk: A review of the in vitro and in vivo data.’. Nutr Cancer 21 113-131.
66. M MESSINA, E T GUGGER and D L ALEKEL (2001) ‘Soy protein, soybean isoflavones, and bone health: a review of the animal and human data.’. R E C Wildman,(Eds) Handbook of Nutraceuticals and Functional Foods Boca Raton: CRC Press LLC 77-98.
67. N MORABITO, A CRISAFULLI, C VERGARA, A GAUDIO, A LASCO, N FRISINA, R D'ANNA, F CORRADO, M A PIZZOLEO, M CINCOTTA, D ALTAVILLA, R LENTILE and F SQUADRITO (2002) ‘Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study.’. J Bone Miner Res 17 1904-1912.
68. C NAGATA, N TAKATSUKA, S INABA, N KAWAKAMI and H SHIMIZU (1998) ‘Association of diet and other lifestyle with onset of menopause in Japanese women.’. Maturitas 29(2), 105-113.
69. C NAGATA, H SHIMIZU, R TAKAMI, M HAYASHI, N TAKEDA and K YASUDA (2002) ‘Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women.’. Osteoporosis Int 13 200-204.
70. B E NORDIN (1997) ‘Calcium and osteoporosis.’. Nutrition 13 664-686.
71. N OMI, S AOI, K MURATA and I EZAWA (1992) ‘Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with bone strength in ovariectomized osteoporotic rats.’. J Nutr Sci Vitaminol 40 201-211.
72. P D O'LOUGHLIN and H MORRIS (1998) ‘Oestrogen deficiency impairs intestinal calcium absorption in the rat.’. J Physiol 511 313-322.
73. C PICHERIT, V COXAM, C BENNETAU-PELISSERO, S KATI-COULIBALY, M-J DAVICCO, P LEBECQUE and J-P BARLET (2000) ‘Daidzein is more efficient than genistein in preventing ovariectomyinduced bone loss in rats.’. J Nutr 130 1675-1681.
74. C PICHERIT, C BENNETAU-PELISSERO, B CHANTERANNE, P LEBECQUE, M-J DAVICCO, J-P BARLET and V COXAM (2001) ‘Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats.’. J Nutr 131 723-728.
75. C PICHERIT, B CHANTERANNE, C BENNETAU-PELISSERO, M-J DAVICCO, P LEBECQUE, J-P BARLET and V COXAM (2001) ‘Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomized rat.’. Br J Nutr 85 307-316.
76. S M POTTER, J A BAUM, H TENG, R J STILLMAN, N F SHAY and J W ERDMAN JR (1998) ‘Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women.’. Am J Clin Nutr 68 79S-1375S.
77. R L PRINCE and I DICK (1997) ‘Oestrogen effects on calcium membrane transport: a new view of the inter-relationship between oestrogen deficiency and age-related osteoporosis.’. Osteoporosis Int 7 150-154.
78. R L PRINCE, M SMITH, I M DICK, R I PRICE, P G WEBB, N K HENDERSON and M M HARRIS (1991) ‘Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy.’. N Eng J Med 325 1189-1195.
79. C M RASSI, M LIEBERHERR, G CHAUMAZ, A POINTILLART and G COURNOT (2002) ‘Down-regulation of osteoclast diferrentiation by daidzein via caspase 3.’. J Bone Min Res 17 630-638.
80. K REINLI and G BLOCK (1996) ‘Phytoestrogen content of foods - a compendium of literature values.’. Nutr Cancer 26 123-148.
81. M RICHELLE, S PRIDMORE-MERTEN, S BODENSTAB, M ENSLEN and E A OFFORD (2002) ‘Hydrolysis of isoflavone glycosides to aglycones by β-glycosidase does not alter plasma and urine isoflavone pharmacokinetics.’. J Nutr 132 2587-2592.
82. B L RIGGS, S KHOSLA and L J MELTON III (1998) ‘A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.’. J Bone Min Res 13 763-773.
83. R RIZZOLI, R AMMANN, S BOURRIN, T CHEVALLEY and J-P BONJOUR (2001) ‘Protein intake and bone homeostasis.’. P Burckhardt, B Dawson-Hughes, R P Heaney,(Eds) Nutritional aspects of osteoporosis San Diego: Academic Press 219-235.
84. G A RODAN and T J MARTIN (2000) ‘Therapeutic approaches to bone diseases,’. Science 289 1508-1514.
85. I R ROWLAND, H WISEMAN, T A SANDERS, H ADLERCREUTZ and E A BOWEY (2000) ‘Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora.’. Nutr Cancer 36 27-32.
86. G RUSSELL (2001) ‘Introduction: bone metabolism and its regulation.’. R Eastell, M Baumann, N R Hoyle, L Wieczorek,(Eds) Bone Markers Biochemical and Clinical Perspectives London: Martin Dunitz Ltd. 1-26.
87. M A SALIH, S H SIMS and D N KALU (1996) ‘Putative intestinal estrogen receptor: evidence for regional differences.’. Mol. Cell Endocrinol 121 47-55.
88. A SCHAAFSMA (2001) ‘Delay of natural bone loss by higher intakes of specific minerals and vitamins.’. Crit Rev Food Sci Nutr 41(3), 225-249.
89. K D R SETCHELL (1998) ‘Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones.’. Am J Clin Nutr 68(S), 1333S-1346S.
90. K D R SETCHELL and A CASSIDY (1999) ‘Dietary isoflavones: Biological effects and relevance to human health.’. J Nutr 129 67S-758S.
91. K D R SETCHELL, N M BROWN, P DESAI, L ZIMMER-NECHEMIAS, B E WOLFE, W T BRASHEAR, A S KIRSCHNER, A CASSIDY and J E HEUBI (2001) ‘Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.’. J Nutr 131 75S-1362S.
92. J L SLAVIN, S C KARR, A M HUTCHINS and J W LAMPE (1998) ‘Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion.’. Am J Clin Nutr 68 5S-1492S.
93. Y SOMEKAWA, M CHIGUCHI, T ISHIBASHI and A TAKESHI (2001) ‘Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women.’. Obstet Gynecol 97 109-115.
94. E SUGIMOTO and M YAMAGUCHI (2000) ‘Anabolic effect of genistein in osteoblastic MC3T3-E1 cells.’. Int J Mol Med 5 515-520.
95. E SUGIMOTO and M YAMAGUCHI (2000) ‘Stimulatory effect of daidzein in osteoblastic MC3T3-E1 cells.’. Biochem Pharmacol 59 471-475.
96. K D R SETCHELL, N M BROWN and E LYDEKING-OLSEN (2002) ‘The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones.’. J Nutr 132 3577-3584.
97. S L TEITELBAUM (2000) ‘Bone resorption by osteoclasts.’. Science 289 1504-1508.
98. H TOBE, O KOMIYAMA, Y KOMIYAMA and H B MARUYAMA (1997) ‘Daidzein stimulation of bone resorption in pit formation assay.’. Biosci Biotechnol Biochem 61 370-371.
99. K TSUCHIDA, S MIZUSHIMA, M TOBA and K SODA (1999) ‘Dietary soybeans intake and bone mineral density among 995 middle-aged women in Yokohama.’. J Epidemiol 9 14-19.
100. N TSUNODA, S POMEROY and P NESTEL (2002) ‘Absorption in humans of isoflavones from soy and red clover is similar.’. J Nutr 132 2199-2201.
101. T UESUGI, T TODA, K. TSUJI and H ISHIDA (2001) ‘Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin.’. Biol Pharm Bull 24 368-372.
102. T UESUGI, Y FUKUI and Y YAMORI (2002) ‘Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study.’. J Am Coll Nutr 21 97-102.
103. A VINCENT and L A FITZPATRICK (2000) ‘Soy isoflavones: are they useful in menopause?’. Mayo Clin Proc 75 1174-1184.
104. H-J WANG and P A MURPHY (1994) ‘Isoflavone content in commercial soybean foods.’. J Agric Food Chem 42 1666-1673.
105. H-J WANG and P A MURPHY (1994) ‘Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location.’. J Agric Food Chem 42 1674-1677.
106. K E WANGEN, A M DUNCAN, B E MERZ-DEMLOW, X XU, R MARCUS, W R PHIPPS and M S KURZER (2000) ‘Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women.’. J Clin Endocrin Metab 85(9), 3043-3048.
107. S WATANABE, M YAMAGUCHI, T SOBUE, T TAKAHASHI, T MIURA, Y ARAI, W MAZUR, K WAHALA and H ADLERCREUTZ (1998) ‘Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60g baked soybean powder (Kinako).’. J Nutr 128 1710-1715.
108. B A WATKINS and M F SEIFERT (2001) ‘Lipids as modulators of bone remodelling.’. Curr Opin Clin Nutr Metab Care 4 105-110.
109. X XU, K S HARRIS, H J WANG, P A MURPHY and S HENDRICH (1995) ‘Bioavailability of soybean isoflavones depends upon gut microflora in women.’. J Nutr 125 2307-2315.
110. T YAMAGISHI, E OTSUKA and H HAGIWARA (2001) ‘Reciprocal control of expression of mRNAs for osteoclast differentiation factor and OPG in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis.’. Endocrinol 142 3632-3637.
111. M YAMAGUCHI and Y H GAO (1998) ‘Inhibitory effect of genistein on bone resorption in tissue culture.’. Biochem Pharmacol 55 71-76.
112. M YAMAGUCHI and E SUGIMOTO (2000) ‘Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: Activation of aminoacyl-tRNA synthetase.’. Mol Cell Biochem 214 97-102.
113. M YAMAGUCHI and Z J MA (2001) ‘Effect of polyphenols on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro.’. Biol Pharm Bull 24 1437-1439.
114. H YOSHIDA, T TERAMOTO, K IKEDA and Y YAMORI (2001) ‘Glycitein effect on suppressing the proliferation and stimulating the differentiation of osteoblastic MC3T3-E1 cells.’. Biosci Biotechnol Biochem 65 1211-1213.
115. H J YOUNG, D R DOERGE, F A KIMBERLY, C D ALLRED and W G HELFERICH (2002) ‘Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.’. Cancer Res 62 2474-2477.